Next 10 |
home / stock / mpln / mpln articles
Shares of Lands’ End, Inc. (NASDAQ:LE) fell sharply during Wednesday's session following first-quarter results. Lands’ End reporte...
Shares of GameStop Corp. (NYSE:GME) rose sharply in today's pre-market trading after the company announced it has completed its at-the-market ...
U.S. stock futures were mostly higher this morning, with the Nasdaq futures gaining around 0.5% on Tuesday. Shares of Hello Group Inc. (NASDAQ:MOMO...
Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday's session after the company announced that it will voluntarily ...
U.S. stocks were higher, with the Nasdaq Composite jumping over 50 points on Monday. Shares of Tesla, Inc. (NASDAQ:TSLA) rose sharply during Monday...
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, whic...
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, whic...
Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial res...
U.S. stocks traded lower, with the Dow Jones falling around 100 points on Monday. Here are some big stocks recording gains in today’s session...
News, Short Squeeze, Breakout and More Instantly...
MultiPlan Corporation Class A Company Name:
MPLN Stock Symbol:
NYSE Market:
MultiPlan Corporation Class A Website:
MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today th...
Company’s PlanOptix ™ and BenInsights ™ solutions recognized for reducing healthcare costs MultiPlan Corporation (NYSE: MPLN) (“MultiPlan” or the “Company”), a leading value-added provider of data analytics and technology-enab...
2024-06-25 17:15:03 ET Piper Sandler analyst issues NEUTRAL recommendation for MPLN on June 25, 2024 04:16PM ET. MPLN was trading at $0.3575 at issue of the analyst recommendation. Historical Analyst Recommendations Latest 10 recommendations